Thread by @VincentRK

You don't get much credit for editorials in academic promotions. But I have found them quite useful to advance a new concept, make an argument for change, or for advocacy. #MedTwitter

Here are 5 editorials that I hope highlight how you can make it work.

See thread.

1/ Redefining Myeloma
We wrote this to make the case that the disease definition for multiple myeloma was outdated, and made suggestions on how it should be revised. Few years later the definition was changed. @NatRevClinOncol @DianaNrco
nature.com/articles/nrcli…

2/ Strategic Clinical Trials
In this editorial, we called for disclosure of the true purpose of a clinical trial which is often different than the primary objectives, & also for strategic investigator initiated randomized trials. @TheLancet @jocalynclark thelancet.com/journals/lance…

3/ The high cost of insulin in the US: An urgent call to action. An advocacy piece.

I wrote this in absolute frustration. Im still frustrated. Nothing changes. #insulin4all @MayoProceedings mayoclinicproceedings.org/article/S0025-…

4/ The screening imperative for myeloma

I try to make the case that we should screen for myeloma in high risk populations. It's not an easy call. @Nature nature.com/articles/d4158…

5/ Treatment of myeloma: Cure versus control.

In elderly patients with potentially incurable cancer should we try to take risks and go for the cure, or try to maximize quality of life and control the disease like hypertension? @MayoProceedings mayoclinicproceedings.org/article/S0025-…